International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 3 , Pages 928-933, 1 July 2009

Radiation Response in Two HPV-Infected Head-and-Neck Cancer Cell Lines in Comparison to a Non–HPV-Infected Cell Line and Relationship to Signaling Through AKT

  • Anjali K. Gupta, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA
    • Corresponding Author InformationReprint requests to: Anjali K. Gupta, M.D., Department of Radiation Oncology, University of Iowa, Hospitals and Clinics, 200 Hawkins Drive, 1625 PFP LLWA, Iowa City, IA 52242. Tel: (319) 384-6135; Fax: (319) 356-1530
    • ,
  • John H. Lee, M.D.

      Affiliations

    • Sanford ENT-H&N Surgery, Sanford Cancer Research, Sioux Falls, SD
    • ,
  • Werner W. Wilke, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA
    • ,
  • Harry Quon, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
    • ,
  • Gareth Smith, B.A.

      Affiliations

    • Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA
    • ,
  • Amit Maity, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
    • ,
  • John M. Buatti, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA
    • ,
  • Douglas R. Spitz, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA

Received 18 November 2008; received in revised form 10 February 2009; accepted 2 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by NIH grant R21 CA121580-01A1 (A.K.G.).

 Presented at 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, September 21–25, 2008.

 Anjali K. Gupta has a use patent pending on Nelfinavir as a radiation sensitizer. No other conflicts of interest to report.

PII: S0360-3016(09)00363-0

doi:10.1016/j.ijrobp.2009.03.004

International Journal of Radiation Oncology * Biology * Physics
Volume 74, Issue 3 , Pages 928-933, 1 July 2009

Article Tools

* Image Usage & Resolution